Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 9 0
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 69 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 13
Elbasvir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 2 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Mar/08/2021 15 2
MI-30 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
MI-09 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/18/2021 1 0
S-FL-opt/S1 recombinant protein Potential treatment - pre-clinical evidence Experimental Vaccine Feb/08/2021 1 0